老年小细胞肺癌的治疗

doi:10.11904/j.issn.1002-3070.2016.05.016

摘要/Abstract

摘要： 目前老年小细胞肺癌发病率呈上升趋势。小细胞肺癌治疗的主要手段是放疗、化疗以及手术治疗,其治疗目的在于延长患者生命的同时提高生活质量。随着精准放疗时代的到来,放疗在老年人群的治疗中扮演着越来越重要的角色。但老年小细胞肺癌的治疗目前尚无统一标准,本文就老年小细胞肺癌治疗的最新研究进展进行综述。

关键词: 老年人, 小细胞肺癌, 治疗

Abstract: Recently,the incidence rate of small cell lung cancer in elderly patients has been increasing.The mainly therapeutic approach of small cell lung cancer consists of radiotherapy,chemotherapy and surgery,with the treatment purpose of prolonging survival time and improving life quality.As the huge development of accurate radiotherapy technology occurred in the past a few years,radiotherapy could play more and more important roles in the treatment with elderly patients.Yet,there is no unified standards of treatment for small cell lung cancer in elderly patients.Therefore,we give a review on the latest processes and research on the treatment of small cells lung cancer in elderly patients.

Key words: Aged, Small cell lung Cancer, Therapy

中图分类号:

R734.2

肖瑶综述, 徐向英, 胡松柳审校. 老年小细胞肺癌的治疗[J]. 实用肿瘤学杂志, 2016, 30(5): 463-467.

XIAO Yao, XU Xiangying, HU Songliu. Treatment of small cell lung cancer in elderly patients[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(5): 463-467.

参考文献

1 http://seer.cancer.gov/statfacts/html/lungb.html,2015-11-18/2016-04-10.
2 Rossi A,Maione P,Colantuoni G,et al.Treatment of small cell lung cancer in the elderly[J].Oncologist,2005,10(6):399-411.
3 Takada M,Fukuoka M,Kawahara M,et al.Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer:results of the Japan Clinical Oncology Group Study 9104[J].J Clin Oncol,2002,20(14):3054-3060.
4 Fried DB,Morris DE,Poole C,et al.Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer[J].J Clin Oncol,2004,22(23):4837-4845.
5 Turrisi AT,Kim K,Blum R,et al.Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide[J].N Engl J Med,1999,340(4):265-271.
6 Yuen AR,Zou G,Turrisi AT,et al.Similar outcome of elderly patients in intergroup trial 0096:Cisplatin,etoposide,and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma[J].Cancer,2000,89(9):1953-1960.
7 Corso CD,Rutter CE,Park HS,et al.(S041)the role of chemoradiation in elderly limited-stage small-cell lung cancer patients[J].Oncology(Williston Park),2015,29(4 Suppl 1):1-2.
8 Corso CD,Rutter CE,Park HS,et al.Role of chemoradiotherapy in elderly patients with limited-stage small-cell lung cancer[J].J Clin Oncol,2015,33(36):4240-4246.
9 Su J,Zhu S,Liu Z,et al.A study of elderly patients with limited-stage small-cell lung cancer after combined chemoradiotherapy[J].Am J Ther,2012,21(5):371-376.
10 Shukuya T,Takahashi T,Harada H,et al.Chemoradiotherapy for limited-disease small-cell lung cancer in elderly patients aged 75 years or older[J].Jpn J Clin Oncol,2013,43(2):176-183.
11 Arriagada R,Le Chevalier T,Riviere A,et al.Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer:analysis of 505 randomized patients[J].Ann Oncol,2002,13(5):748-754.
12 Auperin A,Arriagada R,Pignon JP,et al.Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.Prophylactic Cranial Irradiation Overview Collaborative Group[J].N Engl J Med,1999,341(7):476-484.
13 Eaton BR,Kim S,Marcus DM,et al.Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer[J].Cancer,2013,119(21):3753-3760.
14 Jackman DM,Johnson BE.Small-cell lung cancer[J].Lancet,2005,366(9494):1385-1396.
15 Janssen-Heijnen ML,Maas HA,Koning CC,et al.Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer[J].J Geriatr Oncol,2014,5(1):71-77.
16 Caprario LC,Strauss GM.The benefit of chemotherapy in elderly patients with small cell lung cancer[J].Expert Rev Anticancer Ther,2014,14(6):645-647.
17 Fisher S,Al-Fayea TM,Winget M,et al.Uptake and tolerance of chemotherapy in elderly patients with small cell lung cancer and impact on survival[J].J Cancer Epidemiol,2012,2012:708936.
18 Quoix E,Breton JL,Daniel C,et al.etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer:a phase ii study[J].Ann Oncol,2001,12(7):957-962.
19 Kim E,Biswas T,Bakaki P,et al.Comparison of cisplatin/etoposide versus carboplatin/etoposide concurrent chemoradiation therapy for limited-stage small cell lung cancer(LS-SCLC)in the elderly population(age >65 years)using national SEER-Medicare data[J].Pract Radiat Oncol,2016,6(5):163-169.
20 Zhu H,Zhou Z,Xue Q,et al.Treatment modality selection and prognosis of early stage small cell lung cancer:retrospective analysis from a single cancer institute[J].Eur J Cancer Care(Engl),2013,22(6):789-796.
21 Jeremic B,Shibamoto Y,Nikolic N,et al.Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer:A randomized study[J].J Clin Oncol,1999,17(7):2092-2099.
22 Yee D,Butts C,Reiman A,et al.Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer[J].Radiother Oncol,2012,102(2):234-238.
23 Palma DA,Warner A,Louie AV,et al.Thoracic radiotherapy for extensive stage small-cell lung cancer:a meta-analysis[J].Clin Lung Cancer,2015,17(4):239-244.
24 Wu D,Fang J,Nie J,et al.Effects of local radiation combined with chemotherapy in the treatment of patients with extensive-stage small cell lung cancer[J].Chin J Lung Cancer,2015,18(5):272-279.
25 Zhu H,Zhou Z,Wang Y,et al.Thoracic radiation therapy improves the overall survival of patients with extensive stage small cell lung cancer with distant metastasis[J].Cancer,2011,117(23):5423-5431.
26 Slotman BJ,Van Tinteren H,Praag JO,et al.Use of thoracic radiotherapy for extensive stage small-cell lung cancer:a phase 3 randomised controlled trial[J].Lancet,2015,385(9962):36-42.
27 Qin T,Zhou N,Zeng YD,et al.Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase[J].Onco Targets Ther,2016,9:1095-1103.
28 Rodrigues G,Macbeth F,Burmeister B,et al.Consensus statement on palliative lung radiotherapy:third international consensus workshop on palliative radiotherapy and symptom control[J].Clin Lung Cancer,2012,13(1):1-5.
29 Kepka L,Olszyna-Serementa M.Palliative thoracic radiotherapy for lung cancer[J].Expert Rev Anticancer Ther,2010,10(4):559-569.
30 Rule WG,Foster NR,Meyers JP,et al.Prophylactic cranial irradiation in elderly patients with small cell lung cancer:findings from a North Central Cancer Treatment Group pooled analysis[J].J Geriatr Oncol,2015,6(2):119-126.
31 Niell HB,Herndon JE,Miller AA,et al.Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer:Cancer and Leukemia Group B Trial 9732[J].J Clin Oncol,2005,23(16):3752-3759.
32 Noda K,Nishiwaki Y,Kawahara M,et al.Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer[J].N Engl J Med,2002,346(2):85-91.
33 Okamoto H,Watanabe K,Kunikane H,et al.Randomised phase iii trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer:jcog 9702[J].Br J Cancer,2007,97(2):162-169.
34 Kim YS,Park SH,Kyung SY,et al.Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer[J].Med Oncol,2011,28(1):342-350.
35 Smit EF,Baas P.Lung cancer in 2015:Bypassing checkpoints,overcoming resistance,and honing in on new targets[J].Nat Rev Clin Oncol,2016,13(2):75-76.

[1]	张佳文,于雁,张薇,曹京燕,罗雯,尚利华. 基于UPLC-TOF/MS的小细胞肺癌患者血清代谢组学研究[J]. 实用肿瘤学杂志, 2019, 33(3): 200-205.
[2]	孙立春,李丹丹,李净,于凤玲. CCDC8和TGF-β1在非小细胞肺癌中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(3): 215-221.
[3]	侯玉雪,李晓莉. Wnt7a与恶性肿瘤的关系及研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 271-275.
[4]	朱琳,张春霞. 纳米载药系统靶向肿瘤干细胞的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 276-279.
[5]	李珊,赵春波,乔文波. 术中放疗在胰腺癌中的应用进展[J]. 实用肿瘤学杂志, 2019, 33(3): 280-283.
[6]	方琳, 刘超, 张纯慧, 张艳桥. 转移性结直肠癌维持治疗的研究现状与治疗策略[J]. 实用肿瘤学杂志, 2019, 33(2): 173-178.
[7]	丁界先, 张津, 陈永刚, 王兴文综述, 王栓科审校. Wnt信号通路与肿瘤发生的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 73-77.
[8]	邢志超综述, 麦威审校. 脂肪肉瘤潜在作用靶点的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 82-86.
[9]	张攀, 张迪综述, 戴晓波审校. 复发鼻咽癌再程放射治疗的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 92-96.
[10]	田洋, 吴华星. 超细鼻胃镜在消化道狭窄性疾病中的临床应用[J]. 实用肿瘤学杂志, 2018, 32(6): 550-554.
[11]	李万祯, 殷俊, 李萍, 林晓辉, 张国前, 张书旭. iR-17在非小细胞肺癌放射抗拒细胞中的表达及作用研究[J]. 实用肿瘤学杂志, 2018, 32(5): 391-397.
[12]	蔡静, 候玥. 非小细胞肺癌患者血清miR-195的表达及其临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 415-419.
[13]	李悦, 徐可, 韩增祥, 孙敏, 樊国华综述, 张勇审校. 结肠癌中肿瘤相关巨噬细胞的作用及靶向治疗的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 450-454.
[14]	王元综述, 孙轶华审校. β-连环蛋白在软组织肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 455-459.
[15]	崔晓燕, 涂青, 甘建辉. 纳布啡与羟考酮自控镇痛对非小细胞肺癌患者术后免疫因子水平影响的比较[J]. 实用肿瘤学杂志, 2018, 32(4): 309-314.